BCPC Balchem Corporation
USBasic MaterialsAs of 2026-07-09 16:00
Why BCPC matters now
Balchem Corporation (BCPC) is a US stock in Basic Materials. The latest InvestLog snapshot shows $163.53 with -1.49% on the session and $5.25B in market capitalization; recent performance reads 1-month +4.21% and YTD +8.19%.
The latest financial table shown here is Q1 2026, with revenue of $270.7M, net income of $40.3M, and EPS of $1.25. Investors can compare that operating picture with valuation signals such as P/E 36.59 and FCF yield 3.3%.
The latest indexable market news headline is "Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $175.50; recent insider activity includes Gilson Erin Leigh filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
36.59
PEG
1.78
P/B
4.17
P/S
5.04
EV/EBITDA
20.11
DCF Value
$170.85
FCF Yield
3.3%
Div Yield
0.6%
Margins & Returns
Gross Margin
36.3%
Operating Margin
21.0%
Net Margin
15.0%
ROE
12.4%
ROA
9.3%
ROIC
11.1%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $270.7M | $40.3M | $1.25 |
| Q4 2025 | $263.6M | $39.2M | $1.21 |
| FY 2025 | $1.04B | $154.8M | $4.75 |
| Q3 2025 | $267.6M | $40.3M | $1.24 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$175.50
Target (Median)
$175.50
Target Range
$162.00 - $189.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Basic Materials
Industry
Chemicals - Specialty
Country
US
Exchange
—
Beta
0.83
Balchem Corporation specializes in the creation, production, and distribution of high-performance specialty ingredients and solutions, catering to diverse sectors including human and animal nutrition, food and pharmaceuticals, medical device sterilization, agricultural plant health, and various industrial applications, operating both domestically and globally. The company organizes its operations into three primary divisions: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment primarily serves the food and beverage industry with essential ingredients. Its extensive product portfolio encompasses spray-dried and emulsified powders, extrusion and agglomeration technologies, specialized lipid blends, liquid flavor delivery solutions, various bases for juices, dairy, chocolate, and cereals, alongside ice cream bases and variegates. Additionally, this segment provides microencapsulation technologies for diverse uses, in addition to human-grade choline nutrients and chelated mineral amino acid products vital for health and wellness. The Animal Nutrition & Health segment delivers microencapsulated products designed to boost the health and milk yield of ruminant animals, while also supplying nutrient supplements. It also leverages chelation technology to improve nutrient absorption across a wide range of production and companion animal species, and offers choline chloride, a key nutrient for the health of monogastric animals. The Specialty Products segment is a supplier of ethylene oxide (EtO), primarily utilized for sterilization within the healthcare sector, including single-use canisters for sterilizing reusable medical devices. Furthermore, it markets propylene oxide, a fumigant effective in controlling insects, microbial spoilage, and reducing bacterial and mold contamination in a variety of food products such as nuts (shelled and processed), spices, cacao beans, cocoa powder, and dried fruits like raisins, figs, and prunes. The segment also provides chelated minerals tailored for high-value agricultural crops. Balchem distributes its offerings through a combination of its direct sales force, independent distributors, and dedicated sales agents. Established in 1967, Balchem Corporation maintains its headquarters in New Hampton, New York.